Eligible patients will be selected based on inclusion and exclusion criteria, and their data will be gathered through patient profile forms, treatment charts, and prescriptions. This includes information on the types and patterns of antidiabetic medications prescribed, frequency of dose changes, and reasons for adjustments. Incidence and details of hypoglycemic episodes will be recorded from patient self-reports and progress records. Maternal and fetal outcomes, such as weight gain, blood pressure, incidence of preeclampsia, birth weight, and gestational age at delivery, will be documented. Additionally, the cost of illness will be analyzed by collecting direct medical costs (medications, diagnostic tests, hospital visits), direct non-medical costs (transportation, medical supplies), and indirect costs (loss of income, caregiver support) from billing records, insurance claims, and patient surveys. Data will be collected at baseline, during each prenatal visit, and at the first postpartum visit to ensure comprehensive tracking of clinical outcomes and treatment costs.